Observational Study on the Use of Ivermectin as an Outpatient Treatment Option for COVID-19

Patrick Robinson

Status: Unknown

Conditions: COVID-19 Respiratory Infection; COVID-19 Pneumonia; Covid19; COVID-19 Acute Bronchitis

Treatments: Drug: Ivermectin

Study type: Observational

Funder types: Other

Identifiers

NCT05045937

Ivermectin Treatment Study #1

Details and patient eligibility

About

Ivermectin is currently being utilized by a number of physicians in the local area. My objective will be to enroll these patients at the time of their evaluation for COVID-19 infection and to follow their progress through their recovery.

Full description

Patients at local physician clinics as well as my own clinic will be enrolled at the time they are evaluated for having COVID-19. Patients enrollment will be voluntary and based upon their request for treatment with Ivermectin. These patients will be questioned on symptoms and the timing of those symptoms in detail. They will then be followed throughout their treatment course to evaluate their recovery experience. Detailed accounts of their symptoms and their resolution will be followed. The study patients will stop being followed when they are either admitted to the hospital or are deemed to be symptom free. Any other medications prescribed to the patients will also be tracked. Medical histories will be taken and documented to make comparisons at the end of the study. Those patients not requesting Ivermectin will also be followed for comparisons at a later date.

Enrollment: 1,000 estimated patients

Sex: All

Ages: 12 to 110 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Between the ages of 12-110 years old
• Has a recently completed COVID test
• Symptomatic and seeking treatment
• Willingness to participate and have follow-up
• Able and willing to take medications and treatment suggestions from the physician

Exclusion Criteria: Lack of symptoms, uncertain of COVID-19 status, outside of age limits for treatment

• No recent COVID test results
• Asymptomatic, even if COVID positive
• Outside of acceptable age range
• Meets criteria for hospital admission
• Unwilling to participate in trial study or have follow-up

Trial design

1,000 participants in 2 patient groups

COVID-19 patients treated with Ivermectin

Description:

This group of patients will be those who requested to be treated with Ivermectin and whom have been prescribed such by different physicians. This group may or may not include those treated with Monoclonal Antibodies or Remdesivir.

Treatment:

Drug: Ivermectin

COVID-19 patients declining Ivermectin and wanting traditional treatment

Description:

This group of patients will be those who do not request to be treated with Ivermerctin and who want to be treated with a more traditional, minimalist approach. This group may or may not include those treated with Monoclonal Antibodies or Remdesivir.